Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
puling granule
- Development stage
- Preclinical
- Lead developer
- Shanghai Sixth People’s Hospital
- Administration
- Oral
01
Overview
Puling granule is a Traditional Chinese Medicine (TCM) formulation developed by the Shanghai Jiao Tong University Affiliated Sixth People's Hospital. It is specifically indicated for the treatment of refractory chronic bone and joint infections, including chronic osteomyelitis. The formulation is used within an integrated traditional Chinese and Western medicine framework to enhance the efficacy of standard treatments like surgical debridement and antibiotics. It is believed to work by reducing local inflammation, improving blood circulation at the infection site, and promoting bone regeneration and tissue repair.
- Brand names
- Puling granule
- Other names
- Puling keli普灵颗粒
Beyond the preview
Go deeper on puling granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on puling granule.